Who is sponsoring NCT04774562?

NCT04774562 is sponsored by Ozum Cetinkaya Eren.

What drugs are being tested in NCT04774562?

Interventions in NCT04774562: Video-Assisted Discharge Education (VADE), Physiotherapy (PT) Program.

What condition does NCT04774562 study?

NCT04774562 studies Total Hip Replacement, Patient Education, Patient Satisfaction, Activities of Daily Living.

Is NCT04774562 still recruiting?

NCT04774562 is currently completed. Last updated 1 March 2021.

Last reviewed 2021-03-01 · How we verify

NCT04774562

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Video-Assisted Discharge Education After Total Hip Replacement Surgery

Completed NA Last updated 1 March 2021

What this trial tests

NA trial testing Video-Assisted Discharge Education (VADE) in Total Hip Replacement in 31 participants. Completed in 19 July 2019.

Timeline

4 September 2018

Primary endpoint
1 January 2019

19 July 2019

Quick facts

Lead sponsor	Ozum Cetinkaya Eren
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	31
Start date	4 September 2018
Primary completion	1 January 2019
Estimated completion	19 July 2019
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Video-Assisted Discharge Education (VADE)
Physiotherapy (PT) Program

Conditions studied

Total Hip Replacement — all drugs for Total Hip Replacement →
Patient Education — all drugs for Patient Education →
Patient Satisfaction — all drugs for Patient Satisfaction →
Activities of Daily Living — all drugs for Activities of Daily Living →

Sponsor

Ozum Cetinkaya Eren

Who can join

Adults 25 to 70, any sex, with Total Hip Replacement or Patient Education. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Abstract Objective: The aim of this study was to investigate the effect of a video-assisted discharge education program on activities of daily living, functionality, and patient satisfaction after total hip replacement (THR) surgery. Methods: This study included 31 participants who were randomly divided in the physiotherapy (PT) group (n=18), and the video-assisted discharge education (VADE) group (n=13). Both groups received a physiotherapy program. VADE group was additionally received VADE program. In both groups, all education programs were given face to face. Data were collecting using visual analog scale (VAS), Harris Hip Score (HHS), Nottingham Extended Activities of Daily Living Scale (NEADL), Tampa Scale of Kinesiophobia (TSK) and Patient Satisfaction Questionnaire at 1st week and 3rd month. Practice Implications: The current study has contributed to the development of video-assisted health technologies.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effect of video-assisted discharge education after total hip replacement surgery: a randomized controlled study.
Cetinkaya Eren O, Buker N, Tonak HA, Urguden M. · · 2022 · cited 11× · PMID 35197538 · DOI 10.1038/s41598-022-07146-y

Verify or expand the search:

Other recruiting trials for Total Hip Replacement

Currently open trials in the same condition.

NCT07226700 — Suzetrigine in Total Hip Arthroplasty · Phase 3 · recruiting
NCT07120191 — An Open Label Data Collection Study of My Connect Post-Op, a Post-Operative Communication Tool · recruiting
NCT06878014 — Comparing the Safety and Effectiveness of Different Doses of Morphine Administered in Spinal Anethesia for Pain Relief A · Phase 4 · recruiting
NCT06238960 — Effectiveness of Telerehabilitation in Continuity With Outpatient Physiotherapy After Total Hip Replacement. · NA · recruiting
NCT06628336 — Post-Market Observational Study of the HARMONY® Evolution Implants and Instruments · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04774562 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ozum Cetinkaya Eren
Last refreshed: 1 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04774562.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing